Disturbed microbial ecology in Alzheimer's disease: evidence from the gut microbiota and fecal metabolome.

These findings demonstrate that gut microbial alterations and related metabolic output changes may be associated with pathogenesis of AD, and suggest that fecal markers might be used as a non-invasive examination to assist screening and diagnosis of AD.